Ally Bridge Group Global Life Science Capital Partners V, L.P. — Form D/A
Ally Bridge Group Global Life Science Capital Partners V, L.P. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2023-10-23. $5.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-10-23
- Form: D/A
- Accession: 0001951727-23-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $5.0M
- Investors: 3
- Date of first sale: 2022-10-24
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-462533
Issuer
- Name: Ally Bridge Group Global Life Science Capital Partners V, L.P.
- CIK: 0001951727
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2022
- Address: MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104
- Phone: 345-949 8066
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Fan Yu | Director | Grand Cayman, E9 |
| Shan-ju Yeh | Director | Grand Cayman, E9 |
| n/a ABG Global Life Science Capital Partners V GP, L.P. | Promoter | Grand Cayman, E9 |
Other filings by this issuer (3)
More